No Data
Purple Biotech Reported Final Results From Phase 2 Study Of Its Lead Oncology Drug, CM24, In Patients With Pancreatic Ductal Adenocarcinoma
ADRs Advance; Purple Biotech Ltd. Climbs 150%
12 Health Care Stocks Moving In Monday's Pre-Market Session
Trending Stocks Today | Senti Biosciences Shoots up 445.37%
Express News | Purple Biotech Ltd. Shares Resume Trading
Express News | Purple Biotech Shares Halted On Circuit Breaker To The Upside, Stock Now Up 86.9%
Scott Leininger : just wondered what your thoughts were on what was going on with stock T STAMP